No Photo Available

Last Update

2015-01-24T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Doug Broeska?

Dr. Doug Broeska

Chief Executive Officer

Regenetek Cellular Technologies Inc.

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Regenetek Cellular Technologies Inc.

Background Information

Employment History

President

The CliniCard Inc

Affiliations

Member
International Cellular Medicine Society

Education

BSc

University of Manitoba

PhD

Brightland University

PhD

University of Manitoba

degree

philosophy

Brightland University

Web References (94 Total References)


Broeska said he ...

www.winnipegfreepress.com [cached]

Broeska said he personally funded some of the study's startup costs.

A scan of Doug Broeska's degree in philosophy from Brightland University.
Enlarge Image
A scan of Doug Broeska's degree in philosophy from Brightland University.
After days of silence, the Winnipeg medical researcher who charged multiple sclerosis patients thousands of dollars for overseas stem-cell treatment says he's been "unfairly accused and victimized by inaccurate media reporting" and looks forward to clearing his name.
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research, said media reports he falsified his credentials, overstated the effects of the stem-cell clinical trial, failed to follow up with patients and was recently removed from the study are false.
He said he stands by his role in the "case-based study" where his job was to track patients for followup. He said he has not breached ethical standards and did not give medical advice to patients.
'Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page'
Broeska also released a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no phone numbers, no names of senior administrators or location information, spells the school name incorrectly in one reference and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu in Washington, D.C., includes a stamp saying the oath was sworn before her on Dec. 22, 2015, a date still nearly 11 months away.
Broeska's spokesman, David MacKay of Winnipeg public relations firm ResultzPR, said the date was an error made by the notary, and Broeska is awaiting a correction.
...
Broeska has so far refused to provide a copy of his dissertation, saying Friday releasing it is up to his lawyer.
Broeska originally claimed to have a bachelor of science degree and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary. And, he disputed word this week from Regenetek's Indian partner, Surjo Banerjee of Genesis Ltd., the firm had ended dealings with Regenetek.
"The allegations against Dr. Broeska have not been proven, or even substantiated," said MacKay in an email.
...
"Dr. Broeska has not received any indication from contacts in India that Genesis Ltd. is cutting ties with Regenetek Research."
Broeska also said he personally funded some of the study's startup costs and reiterated Regenetek is a not-for-profit company. He said some patients had their treatment subsidized. "The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism, it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regenetek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."


Broeska said he ...

www.winnipegfreepress.com [cached]

Broeska said he personally funded some of the study's startup costs.

A scan of Doug Broeska's degree in philosophy from Brightland University.
Enlarge Image
A scan of Doug Broeska's degree in philosophy from Brightland University.
After days of silence, the Winnipeg medical researcher who charged multiple sclerosis patients thousands of dollars for overseas stem-cell treatment says he's been "unfairly accused and victimized by inaccurate media reporting" and looks forward to clearing his name.
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research, said media reports he falsified his credentials, overstated the effects of the stem-cell clinical trial, failed to follow up with patients and was recently removed from the study are false.
He said he stands by his role in the "case-based study" where his job was to track patients for followup. He said he has not breached ethical standards and did not give medical advice to patients.
'Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page'
Broeska also released a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no phone numbers, no names of senior administrators or location information, spells the school name incorrectly in one reference and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu in Washington, D.C., includes a stamp saying the oath was sworn before her on Dec. 22, 2015, a date still nearly 11 months away.
Broeska's spokesman, David MacKay of Winnipeg public relations firm ResultzPR, said the date was an error made by the notary, and Broeska is awaiting a correction.
...
Broeska has so far refused to provide a copy of his dissertation, saying Friday releasing it is up to his lawyer.
Broeska originally claimed to have a bachelor of science degree and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary. And, he disputed word this week from Regenetek's Indian partner, Surjo Banerjee of Genesis Ltd., the firm had ended dealings with Regenetek.
"The allegations against Dr. Broeska have not been proven, or even substantiated," said MacKay in an email.
...
"Dr. Broeska has not received any indication from contacts in India that Genesis Ltd. is cutting ties with Regenetek Research."
Broeska also said he personally funded some of the study's startup costs and reiterated Regenetek is a not-for-profit company. He said some patients had their treatment subsidized. "The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism, it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regenetek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."


Doug ...

www.winnipegfreepress.com [cached]

Doug Broeska

Enlarge Image
Doug Broeska (LINKEDIN)
...
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research says media reports that he falsified his credentials, overstated the effects of the stem cell clinical trial, failed to follow up with patients and was recently asked to step down as the study's researcher are false.
He said he stands by his role in the "case-based study" where his job was to track patients for follow-up. He said he has not breached ethical standards and did not give medical advice to patients.
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland’s website includes no contact or location information, spells “Brightland� incorrectly and is linked to a well-known degree mill operator
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no contact or location information, spells "Brightland" incorrectly and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu, a notary public in Washington, D.C., includes a stamp saying the oath was sworn before her Dec. 15, 2015, a date that has not yet occurred.
Broeska originally claimed to have a BSc and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary.
"There is significant cost to conduct the research and administer the treatment and follow up especially since the research is being conducted at a hospital in Pune, in India," said Broeska. "The reason why India was selected is because it has enabling legislation that permits and supports this method of research. Canada and the U.S. do not have medical regulations that support private stem cell treatment trials. These are the reasons why Health Canada is not involved in overseeing this research."
Broeska also said he personally funded some of the study's startup costs, and reiterated that Regenetek is a not-for-profit company. He said some patients had their treatment subsidized.
"The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regentek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."
Statement from Doug Broeska
...
Updated on Friday, January 23, 2015 at 10:57 AM CST: Adds statement from Broeska


Doug ...

www.winnipegfreepress.com [cached]

Doug Broeska

Enlarge Image
Doug Broeska (LINKEDIN)
...
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research says media reports that he falsified his credentials, overstated the effects of the stem cell clinical trial, failed to follow up with patients and was recently asked to step down as the study's researcher are false.
He said he stands by his role in the "case-based study" where his job was to track patients for follow-up. He said he has not breached ethical standards and did not give medical advice to patients.
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland’s website includes no contact or location information, spells “Brightland� incorrectly and is linked to a well-known degree mill operator
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no contact or location information, spells "Brightland" incorrectly and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu, a notary public in Washington, D.C., includes a stamp saying the oath was sworn before her Dec. 15, 2015, a date that has not yet occurred.
Broeska originally claimed to have a BSc and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary.
"There is significant cost to conduct the research and administer the treatment and follow up especially since the research is being conducted at a hospital in Pune, in India," said Broeska. "The reason why India was selected is because it has enabling legislation that permits and supports this method of research. Canada and the U.S. do not have medical regulations that support private stem cell treatment trials. These are the reasons why Health Canada is not involved in overseeing this research."
Broeska also said he personally funded some of the study's startup costs, and reiterated that Regenetek is a not-for-profit company. He said some patients had their treatment subsidized.
"The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regentek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."
Statement from Doug Broeska
...
Updated on Friday, January 23, 2015 at 10:57 AM CST: Adds statement from Broeska


Doug ...

www.winnipegfreepress.com [cached]

Doug Broeska

Enlarge Image
Doug Broeska (LINKEDIN)
...
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research says media reports that he falsified his credentials, overstated the effects of the stem cell clinical trial, failed to follow up with patients and was recently asked to step down as the study's researcher are false.
He said he stands by his role in the "case-based study" where his job was to track patients for follow-up. He said he has not breached ethical standards and did not give medical advice to patients.
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland’s website includes no contact or location information, spells “Brightland� incorrectly and is linked to a well-known degree mill operator
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no contact or location information, spells "Brightland" incorrectly and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu, a notary public in Washington, D.C., includes a stamp saying the oath was sworn before her Dec. 15, 2015, a date that has not yet occurred.
Broeska originally claimed to have a BSc and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary.
"There is significant cost to conduct the research and administer the treatment and follow up especially since the research is being conducted at a hospital in Pune, in India," said Broeska. "The reason why India was selected is because it has enabling legislation that permits and supports this method of research. Canada and the U.S. do not have medical regulations that support private stem cell treatment trials. These are the reasons why Health Canada is not involved in overseeing this research."
Broeska also said he personally funded some of the study's startup costs, and reiterated that Regenetek is a not-for-profit company. He said some patients had their treatment subsidized.
"The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regentek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."
Statement from Doug Broeska
...
Updated on Friday, January 23, 2015 at 10:57 AM CST: Adds statement from Broeska

Similar Profiles

Other People with this Name

Other people with the name Broeska

Marshall Broeska
Ranger Insurance Inc

Chris Broeska
Fuse Animation

John Broeska
Marlboro Plywood Sales

John Broeska
McIlveen Lumber Industries Ltd

Serge Broeska
Red River College

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory